Long-Term Follow-Up of Autoimmune Pancreatitis: Characteristics of Chronic Disease and Recurrence
Autoimmune pancreatitis is a unique disease, characterized by lymphoplasmacytic inflammation in the acute stages. However, the active clinical features are unlikely to persist for long periods. Through long-term follow-up, we investigated the disease course in 51 patients with autoimmune pancreatitis. We found recurrence in 21 (41%) patients and pancreatic stone formation in 9 (18%) patients. Pancreatic stone formation was significantly more frequent in the recurrence group (7/21, 33%), compared with the nonrecurrence group (2/30, 7%). Moreover, we found high serum immunoglobulin G4 concentrations in 13 of 175 (7.4%) patients with ordinary chronic pancreatitis. This suggested that pancreatic stone formation is closely associated with recurrence and that autoimmune pancreatitis might transform into ordinary chronic pancreatitis after several recurrences. We found that the immune complex level, with a cutoff value of 10 μg/dL, served as a good predictor of recurrence, with high sensitivity (61.9%), specificity (70.0%), and efficacy (66.7%). We also confirmed that HLA and cytotoxic T-lymphocyte antigen-4 polymorphisms were useful predictors for AIP recurrence.
⁎Center for Health, Safety and Environmental Management, Shinshu University, Matsumoto, Japan
‡Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan
Reprint requests Address requests for reprints to: Shigeyuki Kawa, Center for Health, Safety and Environmental Management, Shinshu University, 3-1-1Asahi, Matsumoto 390-8621, Japan. fax: (81) 263-37-2183
Conflicts of interest The authors disclose no conflicts.
Funding This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (15659167, 16390205, and 20590805); by a grant from Intractable Diseases, Health, and Labor Sciences Research, Japan; and by a grant from the Pancreas Research Foundation of Japan.